Dr. Stephanie Ann Salas, MD

Dr. Salas practices at Trios Southridge Hospital in Kennewick, Washington, part of Lifepoint Health.

Dr. Salas' NPI, 1154332765, was assigned on August 10, 2006. Dr. Salas graduated from University Of Florida College Of Medicine in 1999. Dr. Salas holds Florida license ME136340.

Dr. Salas' primary practice is Trios Southridge Hospital, at 3780 Plaza Way, Kennewick, WA 99338 in Benton County. The practice phone is (509) 586-6111. Dr. Salas also practices at Trios Southridge Hospital, 3810 Plaza Way, Kennewick, WA 99338.

Dr. Salas' primary practice is Trios Southridge Hospital in Kennewick, Washington, part of Lifepoint Health. Dr. Salas is also affiliated with West Tennessee Healthcare Jackson-Madison County General Hospital. The medical group on file is Northwest Hospital Medicine Physicians. Dmand AI also links Dr. Salas to 4 more hospitals, 12 medical groups, 2 physician offices, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salas practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Salas' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Salas is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Salas' licenses on file in 15 states: Florida, Connecticut, New Hampshire, Tennessee, Georgia, Pennsylvania, Nevada, New York, Alabama, Colorado, Idaho, West Virginia, Michigan, Washington and New Mexico.

Dmand AI lists acute diabetes, cardiac arrhythmia, circulatory problems in extremities, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, gastrointestinal inflammation and gastrointestinal obstruction among the conditions Dr. Salas treats.

CMS data shows 141 Medicare services from Dr. Salas across 2 procedure codes in 2024, for 155 Medicare patients. Medicare paid $13,404 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Salas in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salas' median patient age at 69, with 52% women.

In 2024, Dr. Salas wrote 19 Medicare Part D claims. 84% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $31 in total drug cost. In 2022, CMS named 90 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Salas for performance year 2024, reported as part of a group. Dr. Salas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 45 general payments to Dr. Salas from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $412.

Dr. Salas graduated from University Of Florida College Of Medicine in 1999. Dr. Salas is a member of SHM.

Dr. Salas is in network with 12 carriers, including Blue Cross Blue Shield of Michigan, Highmark and Cigna. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.